Waldenstrom's macroglobulinemia: Treatment option analysis

I am writing this page to document the thought process I am using to decide how I would like to be treated for WM. I hope it is useful to me, to the physicians advising me, as well as to anyone else in a similar boat.

These are my personal opinions. Your conclusions may differ from mine. The purpose of this page is just to explain my reasoning behind each therapy.

First, I'm extremely grateful to doctors Ranjana Advani (Stanford), and Irene Ghobrial and Steve Treon (DFCI) for putting up with my endless amount of questioning. Sadly, the information you need to make the best decision isn't readily available on the web, so I've used up a lot of their precious time to explain things to me and for that I am very grateful and I've tried my best to accurately summarize it here so others can benefit from what I've learned.

My present situation is I'm a 50 years old male with an hct of 32, hgb of 10.7, and IgM serum of 4010, and SV of 2.9. Latest BMB was 40 to 50% involved. The numbers for the hct and hgb are a bit "pumped up" from what they would be because I was given 5 rounds (1 week per round) of IV iron (Ferrlecit). I was asymptomatic (other than the anemia) until recently when I noticed blurry vision in my right eye that would come and go. Treon told me to see an ophthalmologist immediately. My pupils were dilated (note: Maureen who teaches ocular disease, recommends with an IGM of 4,0000 one should have a dilated eye examination at least twice a year) and two different docs looked into my eyes looking for sausaging and/or enlarged veins. They said everything was normal except for a small drop of blood in the periphery of my right retina which they said was recent. Both eye doctors said both the drop of blood (a peripheral retina hemorrhage) and the blurred vision was consistent with a high SV.

Note: that there isn't a formula for IgM level and SV. For example, one person reported IGM at 4000 (same as me) and 4 viscosity (which is way higher than my 2.9). However, the relationship is pretty linear for most datapoints (see Arch Ophthalmol -- Hyperviscosity-Related Retinopathy in Waldenstrom Macroglobulinemia, November 2006, Menke et al. 124 (11) 1601, Figure CS60051F1).

Upon hearing the news, Treon told me to drop out of the statin clinical trial, get 3 rounds of PP (1x every other day for 3 sessions total; about 90 minutes per session), then start CPR which would be 1x every 3 weeks for a minimum of 4 cycles and we'll go from there.

As I'm writing this on Saturday December 8, I just finished by first PP round. Treatment day for CPR is scheduled for Thursday. So if I'm going to make a different decision, I don't have a lot of time.

There is not enough known about WM to make a definitive treatment recommendation and there is a cost/benefit tradeoff that different people weigh differently. That is why 3 different docs gave me 3 different treatment recommendations on the same symptoms. Everyone reacts differently and there isn't a physician in the world who can accurately predict in advance what treatment(s) are going to work on what patients and to what extent and for how long. Nobody can predict CRs for any given in advance. However, there is lots of data on what treatments are effective against your symptoms, e.g., if you have swollen lymph nodes, some treatments are more effective than others in reaching that. And there is lots of data on what treatments, in aggregate, produce the best results.

There is also a difference in philosophy of whether to start by treating pretty aggressively when you have your best shot (e.g., CPR as a first treatment), or to treat starting with low side-effect drugs (e.g., Rituxan only) and then escalating to harder drugs (e.g., CPR) if you don't respond or stop responding.

I asked three different docs and got 3 different opinions for my case. Of course, there are many more options available, but these are the 3 most favored by my physicians. My 3 options being:

  1. CPR
  2. Rituxan only
  3. Rituxan and Velcade (either off label or as part of a clinical trial)

For option 3, there are two variants. I could go on the Velcade + Rituxan clinical trial that Irene is doing. Or, subject to the approval of my physician (a low-probability event!), I could design my own off-label therapy since Velcade is FDA approved.

The V+R clinical trial at DFCI run by Ghobiral is Velcade 1.6 mg/m2 once a week for 3 weeks on an one week off for a total of 6 cycles ( 6 months). Rituxan once a week for 4 weeks for cycle1 and cycle 4 (first and 4th month) based on the extended rituxan trial.

If I "designed my own", I'd do V+R once a week for 4 weeks, while simultaneously doing 20 mg oral simvastatin once a day. If my numbers started heading up, I'd do a 1x/week for 3 weeks of Velcade. So it's similar to the V+R clinical trial, but only repeats the Velcade only if required to keep the numbers heading in the right direction.

CPR (cytoxan-prednisone-rituxan) is basically rCHOP but without the Vincristine/PN risk and without the doxorubicin (aka hydroxyldaunorubicin so it is the H in CHOP). There is a wonderful writeup of rCHOP in "Patient from Hell" (herein after referred to PFH), pp. 67-91 which I've used in the Pro/Con table below because Schneider's writeup talks about things that the doctors may not tell you about beforehand (they didn't tell him beforehand either). rCHOP has more drugs than CPR; CPR basically omits the Vincristine which didn't add much to the effectiveness, but caused lots of peripheral neuropathy (PN).

 

Here are the pro/con arguments for each of the options. ORR=overall response rate (>25% reduction), MRD=median response duration, Minor Response is >=25% reduction; Major Response aka Partial Response is >=50% reduction in IgM.

Option Pro Con ORR MRD
CPR Treon strongly favors this. It's a time proven therapy with the most data behind it (because it's basically an abbreviated form of rCHOP). It gives me the best chance of a permanent CR which is important because the fewer drugs you have to use, the better. The side effects are pretty minimal (relatively benign compared to other chemo therapy). Most importantly, the long term side effects are thought to be insignificant. Plus, there is no risk of PN since there is no Velcade or Vincristine. If you want to minimize the total amount of drugs you have to take to get to stable disease or CR, this is your best shot because the three drugs enhance each other. CPR is also excellent at reaching WM in the lymph nodes (mine are somewhat enlarged). In general, second remissions are harder to achieve than firsts, so if you are going to take a shot, this is the best shot. You could be totally done with just 4 doses (if you are lucky).

Rituxan flare is reduced (compared to Rituxan alone). That's quite important since you don't want to do PP after the treatment since it will get rid of the Rituxan. Also, you don't want to risk eye damage, etc. caused by IgM flare.

You probably won't miss any work. The Prednisone will give you a 5 day "high", so you'll see an energy drop on day 10 to 14 of each cycle.

Since their is no doxorubicin, it's unlikely you'll lose your hair. Most people don't lose their hair from the cytoxan.

Note: Be sure not to wait too long between Compazine doses (PFH, p. 81) and drink plenty of water to help move out the chemo from your body and keep it from toxifying your liver.

When Cytoxan is given via IV, there is minimal toxicity to cells (i.e., permanent cellular damage to stem cells) which is why cytoxan is often given before stem cell harvests.

Note: Cytoxan is 1gm/m2, Prednisone is 100mg/day for 5 days, Rituxan is 375mg/m2. Cycle is 3 weeks. 2 weeks after the 3rd cycle, he wants 3 red tops overnighted to DFCI. Treon and others recommend that C is given before R, but others say it doesn't matter. P is given after the infusion.

There is a some collateral damage from the cytoxan. You have a small chance of losing your hair during treatment and it may not grow back the same way (could be curly or less thick). You will be given extra meds to control side effects (like nausea). Your white cell counts may drop requiring neulasta with the second cycle. According to PFH (pg. 11), 20% of patients end up needing Neupogen or neulasta due to low white cell counts (neutrophils) during chemo, but at my age, it's less than 20% and PFH was on CHOP, not CPR which is more mild. Worst case is you may have to stay at home for a week (PFH, p.11), but most don't lose any time at work. Food will taste pretty bad while you are on chemo (PFH, pg. 83), although one person said a few puffs of marijuana gets rid of the bad chemo feeling and restores your taste. You'll probably suffer from a bad temper when you do a cold-turkey stop on the prednisone in each cycle (PFH, p. 82-83 and the story on p. 87).

Your white and red blood cells and platelets may temporarily decrease.  This can put you at increased risk for infection, anemia and/or bleeding.

Your ability to conceive or father a child may be affected by Cytoxan

Prednisone will make you hungry and cause you to gain weight. It will also make it very hard to sleep.

Of course, the above are relatively minor, short-lived consequences. However, some people have reported some loss of mental and physical vitality after lots chemo treatments (but not 4 doses of this one specifically). If you only took less than 8 cycles of CPR and have long term mental or physical vitality differences, please let me know!

There is a slight risk of developing a blood cancer such as leukemia or myelodysplasia after taking Cytoxan. 

Chemo drugs may permanently affect brain function (e.g., chemo brain).

CAUTIONS: See Cytoxan, Cyclophosphamide, Neosar - Chemotherapy and Side Effects

80% get at least a 50% IgM reduction after 6 to 8 cycles 10% to 20% are estimated to get CRs on CPR per Treon verbal
Rituxan Advani favors this as an initial therapy. Rituxan is a very targeted therapy very little "collateral damage" with good results. Your numbers can get better for years after your last treatment (because you are killing both the B lymphocyte and the lymphoplasmacytic cells, both of which express CD20).

Her reasoning is to start with this, see how it goes, and escalate later to CPR, R + V, or something else if needed. You risk only having wasted a little time. R has very little side effects and mostly limited to the first hour of infusion. You likely aren't going to miss work or be incapacitated in any way.

The fewer the drugs, the less the side effects.

The good thing about R alone is you can chart your personal reaction to R so you can better plan the timing of future treatments and maintenance. In engineering, we'd call it plotting out the impulse response.

A start with R alone seems intuitively more consistent with the disease. Before my vision problems, it was debatable as to whether I "needed" treatment. The vision symptom pushes me over that line. But CPR is like chemical warfare compared to R only which is like a surgical strike. Intuitively it feels a bit odd to go from "treatment optional" to chemical warfare. However, on the other hand, there is a good case to be made for CPR above since the weapons are synergistic with each other.

Nobody ever gets a CR from Rituxan alone, so you are going to have to do more treatments after this. If you want to go for a quick possibly permanent fix in just a few visits, this isn't it.

It is unknown if starting with R only reduces your chances for best effect compared to CPR as an initial treatment, but Advani thinks probably not. However, if you want to be super safe, you should assume that your best shot is your first shot; for example, see the story of Sharon below where R-CVP worked for 18 months then everything stopped working.

You risk the biggest R flare using R alone. CPR has less flare and V+R has even lower IgM flare risk (and lower flares if they do occur).

 

For 4 cycles, there is 27% partial response (>50% igm decrease). For 4+4, it is 40% to 45% PR.

There are never any CRs.

longest mean was 16 months (Dimopoulos) per Table 7 in Merlini, Treon
R + V (clinical trial) Ghobrial favors this approach. Her reasoning is that it has minimal side effects, but about the same success numbers as CPR. So the benefits are the same as CPR, but the strain on your body is minimal and confined pretty much to a low risk of PN that appears to be both temporary and reversible. On her clinical trial, the amount of PN was minimal and it was all reversible. Chance of R flare is minimal and if there is one, it's relatively small.

You can join the clinical trial at DFCI and help add to the knowledge of this disease.

People have reported great efficacy with Velcade alone and there is a synergistic effect with Rituxan.

 

Others claim that in test results in other lymphomas, Velcade even once a week can cause significant PN. Some people never experience PN with Velcade, even at 2X/week dosage over 4 years. If you start experiencing PN with Velcade, my opinion is you should stop immediately. Guy Sherwood tried to be a hero since he was getting great numbers with Velcade on Treon's trial, but later regretted his toughing out the PN during treatment; after treatment stopped, he suffered through 18 months of excruciatingly painful PN.

There is less data on R + V than on CPR.

Unlike with Rituxan, there are reports that the gains you make while on V disappear pretty rapidly after you stop taking it.

   
R + V (custom) Should produce a better benefit than R alone, but since there are only 4 V doses, the PN should be minimal if at all. So this should be better than R alone, with no additional side effects. Very hard to find a physician who will allow you to design your own treatment protocol, not matter how logical it is.

Note: That is too bad in my opinion because each patient is different in their response and each of us have a different risk-reward metric. It would be nice if medicine can be tailored to our individual responses rather than applied cookie cutter style to all patients, but I can also understand why this isn't done (because docs shouldn't experiment on patients outside of clinical trials and stick to proven regimens).

   

All three doctors are right. We don't know enough to predict in advance for a particular patient, which is the "best" course of treatment. They are all good choices and I respect their reasoning. Reading it over, it is indeed very hard to pick a winner as all three doctors make an excellent case. But I'm glad I have 4 great options to choose from!

Also, whatever I choose, I'm going to try to persuade my doctors that taking 20mg simvastatin a day cannot hurt and has the potential to slow or even reduce my disease. The reason for this is that in my opinion, it is much much better to keep the disease "in check" while it is relatively small, rather than allow it grow to be huge.

When IgMs get to be really huge, your options and time get limited very quickly. For example, Sharon, who is the same age I am, reports the following:

Dx Feb 2003.  Age 51. Treatment R-CVP rendered good results for 18 mos, 
3/06 Rituxan alone no response, 5/06-10/06 R-CVP no response, 12/06
Gleevec no response, 2/07-6/07 Velcade/Rituxin with partial response but had
Terrible pn, 7/07-9/07 Campath no response, 10/07-11/07 Etopiside,
Matulane, Cyclophosphamide and Prednisone with no response, 11/07-present
Pentostatin, Cytoxin with Rituxin just finished 2nd round.

Latest blood test (12/3) shows things are still haywire.  Total protein 12.3 Hgb
6.8, Platelets 7, IGM 9060
. CBC low.  Current receiving weekly platelets and
red blood cell transfusions.  Apheresis knocks IGM down to around 4000 but
jumps back up with in a week.  Neulasta following PCR and Aranesp every 2
weeks.

Here are some other options that have worked for people:

Here is some advice I got:


What I decided


Comments on my decision

Related articles
Waldenstrom's macroglobulinemia: A new approach
Waldenstrom's macroglobulinemia: CPR treatment details

Steve Kirsch home page